Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
11/2003
11/26/2003EP1363877A2 Benzophenones as inhibitors of reverse transcriptase
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363614A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence
11/25/2003US6653485 Particularly effective in Ru-catalyzed asymmetric hydrogenation of beta-ketoesters to beta-hydroxyesters and ruthenium-catalyzed asymmetric hydrogenation of enamides to beta amino acids; catalyst selectivity
11/25/2003US6653321 Stimulating kinase activity of insulin receptor; type II diabetes; hyperglycemia
11/25/2003US6653309 Binding ligands
11/25/2003US6653299 Labelled factor XIIIa substrates
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/20/2003WO2003095420A1 Hydroxy tetrahydro-naphthalenylurea derivatives
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216405 Hydroxycarbonyl or alkyloxycarbonyl or aminohydroxycarbonyl substituted sulfonamide compounds useful as procollagen C-protenase inhibitor
11/20/2003US20030216392 Aryl or heteroaryl substituted ethylcarbonylsulfonamide derivatives used as inhibitors of neutrophils chemotaxis and degranulation induced by interleukin 8
11/20/2003US20030216381 Can bind to Prostaglandin E2 receptors, especially, EP3 receptor and/or EP4 receptor and show antagonizing activity, and may be useful for prevention and/or treatment of disease, for example, pain, allergy, Alzheimer's disease, cancer
11/20/2003US20030216375 Sulfonamide substituted diphenyl thiourea compounds; use thereof in treating IL-8, GRO alpha, GRO beta, GRO gamma, NAP-2, and ENA-78 mediated diseases
11/20/2003US20030215876 Solid phase synthesis with benzylidene linker attaching compound on glass slide; microarrays; drug screening
11/19/2003EP1363345A2 Guanidine derivatives as cations for ambient temperature molten salts in electrochemical power sources
11/19/2003EP1362846A1 Aminoethanol derivatives
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649656 Anticarcinogenic, antiallergen, antishock, and antiasthmatic agents
11/13/2003WO2003093227A1 Tamsulosin derivative
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002002520A8 Compounds to treat alzheimer's disease
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/13/2003US20030212114 Stable emulsion compositions
11/13/2003US20030212071 Controlling blood coagulation
11/13/2003US20030212068 Antiinflammatory agents; antiallergens; antiarthritic agents
11/13/2003US20030212067 Bone disorders; rheumatic diseases; wound healing agents
11/13/2003US20030212049 Antiarthritic agents; osteoporosis; sepsis; antiulcer agents; Crohn's disease
11/13/2003US20030211389 Guanidine derivatives as cations for ambient temperature molten salts in electrochemical power sources
11/12/2003EP1360175A1 1g(a)-amino-n-hydroxy-acetamide derivatives
11/12/2003EP1360174A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/12/2003EP1360173A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use
11/12/2003EP1360167A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use
11/12/2003CN1455873A MRI method involving the use of a hyperpolarized contrast agent
11/12/2003CN1455641A Fungicidal compositions
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/11/2003US6646170 Intermediates for the synthesis of ether compounds
11/11/2003US6646149 Derivitives of spermine or its N12-t-butyl carbamate
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6646009 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
11/11/2003US6645965 Nitrate salts of antihypertensive medicines
11/09/2003CA2428420A1 Guanidine derivatives as cations for ambient temperature molten salts in electrochemical power sources
11/06/2003WO2003091207A2 Method of preparing amine stereoisomers
11/06/2003WO2003091205A1 Sulfamidophenylalkylamines and their production and use
11/06/2003WO2003091204A1 Phenethanolamine derivatives
11/06/2003WO2003090678A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003016270A3 Selective estrogen receptor modulators
11/06/2003WO2002076375A3 Process for the preparation of benazepril
11/06/2003US20030208087 Sulfur compounds such as methyl 2-amino-4-methanesulfonylamino methylbenzoate, used as herbicides
11/06/2003US20030208006 Aromatic imide and aromatic methylidynetrissulfonyl compounds and method of making
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207923 Treatment of autoimmune disease, inflammation and allergy; inhibits release of tumour necrosis factor
11/06/2003US20030207872 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
11/06/2003US20030207871 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors
11/06/2003US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
11/06/2003US20030207823 Novel diabetes imaging probes
11/06/2003US20030207812 Cd45 inhibitors
11/06/2003US20030207201 Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method
11/06/2003CA2483725A1 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003CA2482432A1 Method of preparing amine stereoisomers
11/05/2003EP1359142A1 Perfluorovinyl ether monomer having sulfonamide group
11/05/2003EP1359141A1 Method of friedel-crafts acylation of anilides
11/05/2003EP1359139A1 Terphenyl compounds bearing substituted amino groups
11/05/2003EP1357908A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders
11/05/2003EP1066246B1 Novel cationic couplers and their use for oxidation dyeing
11/05/2003CN1453267A New Dofetilide preparing method
11/04/2003US6641802 Copper sulfat complexes to amino acid
10/2003
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030203944 Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same
10/30/2003US20030203886 Process for the production of clavulanic acid salts
10/29/2003EP1357104A1 Tropolone derivative
10/29/2003EP1356153A2 Alkylated fluorochemical oligomers and use thereof in the treatment of fibrous substrates
10/29/2003EP1355894A1 Amidinophenylalanine derivatives as thrombin inhibitors
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355698A2 Insulin receptor activators for the treatment of metabolic disorders in humans resulting from treatment of hiv infection with hiv protease inhibitors
10/29/2003EP1077935B1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors
10/29/2003CN1452610A Compound, compositions and methods for preventing neurodegeneration in acute and chronic injuries in central nervous system
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1452473A Container assembly for fertilization and culture and embryo transfer and method for fertilization and culture employing such container
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/28/2003US6639107 Cyclopentyl sulfonamide derivatives
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003CA2249786C Difluoro statone analogs
10/23/2003WO2003087085A1 Heterocyclic amide derivatives as cytokine inhibitors
10/23/2003WO2003086605A2 Functionalized ionic liquids, and methods of use thereof
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders
10/23/2003US20030199695 Preparation of 4-(4-flourophenyl)-6-alkyl-2-N-alkansulfonyl-N-alkylamino)pyrimidine-5-carboxylic acid ester.
10/23/2003US20030199571 Useful in treatment and prophylaxis of conditions mediated by s-CD23 or tumor necrosis factor; autoimmune disease, inflammation, allergy
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199520 Sulfonamide hydroxamates
10/23/2003US20030199495 Antagonists of RF-amide neuropeptides
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 177